BioCryst Shows ORLADEYO Cuts HAE Attacks Across All Age Groups
May 30, 2025
New data shared at the 14th C1-inhibitor Deficiency & Angioedema Workshop supports berotralstat use at all stages of life BioCryst Pharmaceuticals, Inc. announced new data which